JPS62236500A - Production of cephalosporin-type antibiotic substance - Google Patents
Production of cephalosporin-type antibiotic substanceInfo
- Publication number
- JPS62236500A JPS62236500A JP8032786A JP8032786A JPS62236500A JP S62236500 A JPS62236500 A JP S62236500A JP 8032786 A JP8032786 A JP 8032786A JP 8032786 A JP8032786 A JP 8032786A JP S62236500 A JPS62236500 A JP S62236500A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- medium
- thiosulfate
- cephalosporin
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 230000003115 biocidal effect Effects 0.000 title abstract description 8
- 239000000126 substance Substances 0.000 title abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241001619326 Cephalosporium Species 0.000 claims abstract description 12
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims abstract description 10
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 6
- 235000004279 alanine Nutrition 0.000 claims abstract description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 5
- TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical compound CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 claims abstract description 5
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 claims abstract description 5
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims abstract description 5
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims abstract 6
- 229930186147 Cephalosporin Natural products 0.000 claims description 20
- 229940124587 cephalosporin Drugs 0.000 claims description 20
- 150000001780 cephalosporins Chemical class 0.000 claims description 20
- 239000003242 anti bacterial agent Substances 0.000 claims description 18
- 229940088710 antibiotic agent Drugs 0.000 claims description 18
- 244000005700 microbiome Species 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 4
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 14
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 abstract description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 5
- 229930182817 methionine Natural products 0.000 abstract description 5
- 150000003839 salts Chemical class 0.000 abstract description 5
- 229960003767 alanine Drugs 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 229960001153 serine Drugs 0.000 abstract description 4
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 abstract description 3
- 229940107700 pyruvic acid Drugs 0.000 abstract description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 abstract description 2
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 17
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 241000228417 Sarocladium strictum Species 0.000 description 9
- 239000012526 feed medium Substances 0.000 description 8
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 8
- -1 &-ketoglutaric acid Chemical compound 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N Cephalosporin C Natural products S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 5
- URYAFVKLYSEINW-UHFFFAOYSA-N Chlorfenethol Chemical compound C=1C=C(Cl)C=CC=1C(O)(C)C1=CC=C(Cl)C=C1 URYAFVKLYSEINW-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229960000603 cefalotin Drugs 0.000 description 3
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- XWCFYHBHOFBVIV-UHFFFAOYSA-N Deacetylcephalosporin C Natural products S1CC(CO)=C(C(O)=O)N2C(=O)C(NC(=O)CCCC(N)C(O)=O)C21 XWCFYHBHOFBVIV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- XVOYSCVBGLVSOL-UHFFFAOYSA-N L-cysteine sulfonic acid Natural products OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NOKPBJYHPHHWAN-REOHCLBHSA-N S-sulfo-L-cysteine Chemical compound OC(=O)[C@@H](N)CSS(O)(=O)=O NOKPBJYHPHHWAN-REOHCLBHSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001522306 Serinus serinus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960003791 cefmenoxime Drugs 0.000 description 1
- HJJDBAOLQAWBMH-YCRCPZNHSA-N cefmenoxime Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C HJJDBAOLQAWBMH-YCRCPZNHSA-N 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 1
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- XWCFYHBHOFBVIV-JWKOBGCHSA-N deacetylcephalosporin C Chemical compound S1CC(CO)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@H]21 XWCFYHBHOFBVIV-JWKOBGCHSA-N 0.000 description 1
- FGRVOLIFQGXPCT-UHFFFAOYSA-L dipotassium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [K+].[K+].[O-]S([O-])(=O)=S FGRVOLIFQGXPCT-UHFFFAOYSA-L 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 208000019585 progressive encephalomyelitis with rigidity and myoclonus Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940041008 second-generation cephalosporins Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229940041007 third-generation cephalosporins Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
11直A社皿庄訊
本発明は発酵法によるセファロスポリン系抗生物質の製
造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing cephalosporin antibiotics by fermentation.
従来の技術
セファロスポリン系抗生物質特にセファロチン(Cep
halothin) 、セファ0リジン(Cephal
oridinc)。Prior Art Cephalosporin antibiotics, especially cephalothin (Cep
halothin), Cephal-0 lysine (Cephal
oridinc).
セファレキシン(Cephalexin)などが、ダラ
ム陽性および陰性細菌感染症特に各種抗生物質耐性細菌
感染症に著効を示す数少ない抗生物質として、またセフ
ォチアム(Cefot jam) 、セフメツキシム(
Cefmenoxime)、セファロチン(Cefsu
lodin)などは第二、第三上代のセファロスポリン
として、臨床的に高く評価されていることは周知の通り
である。Cephalexin is one of the few antibiotics that is highly effective against Durham-positive and -negative bacterial infections, especially against various antibiotic-resistant bacterial infections.
Cefmenoxime), Cephalothin (Cefsu
It is well known that cephalosporins (lodin) and the like are highly evaluated clinically as second and third generation cephalosporins.
これらの半合成セファロスポリン抗生物質の出発原料と
しては、微生物の生産するセファロスポリン系抗生物質
が用いられている。Cephalosporin antibiotics produced by microorganisms are used as starting materials for these semisynthetic cephalosporin antibiotics.
これらのセファロスポリン系抗生物質を発酵液中に多量
蓄積させるための方法を見出すべく、今迄に数多くの研
究がなされてきている。たとえば、使用菌株の改良法[
例えば、アンティミクロビアル・エージエンツ・アンド
・ケモセラヒ−(Anti−microbial Ag
ents and Chemotherapy)13.
7〜13(1971!l)など]に関するものや培地成
分の改良による方法[特開昭55−144896.特公
昭52−48196]である。Many studies have been conducted to date to find ways to accumulate large amounts of these cephalosporin antibiotics in fermentation broth. For example, how to improve the strain used [
For example, Anti-microbial agents and chemotherapies
ents and Chemotherapy)13.
7-13 (1971!l)] and methods by improving culture medium components [JP-A-55-144896. Special Publication No. 52-48196].
培地成分の改良に関しては、チオ硫酸塩、硫酸塩、亜ニ
チオン酸塩(亜硫酸塩やジチオナイトとも称される)、
メタ亜硫酸塩、S−スルホシスティンなどが培地に添加
され硫黄源とされているが、発酵収量の向上に伴い、こ
れら含硫化合物に加えメチオニンの添加が必須とされて
いた。Regarding the improvement of culture medium components, thiosulfate, sulfate, dithionite (also called sulfite or dithionite),
Metasulfite, S-sulfocysteine, and the like are added to the culture medium as sulfur sources, but with the improvement of fermentation yield, it has become essential to add methionine in addition to these sulfur-containing compounds.
発明が解決しようとする問題点
微生物の生産するセファロスポリン系抗生物質は半合成
セファロスポリン系抗生物質の出発原料として工業上重
要な物質であり、これを安価にかつ大量に製造すること
は極めて意義深いことである。ところが、前記したメチ
オニンを発酵原料に用いた場合、メチオニンが高価であ
ったり、発酵時に悪臭が発生したり、あるいは発酵時間
が長期間に及ぶなどの欠点を有し、工業的に安価にセフ
ァロスポリン系抗生物質を製造する方法としては必ずし
ら満足できるものではない。Problems to be Solved by the Invention Cephalosporin antibiotics produced by microorganisms are industrially important substances as starting materials for semi-synthetic cephalosporin antibiotics, and it is difficult to produce them cheaply and in large quantities. This is extremely significant. However, when the above-mentioned methionine is used as a raw material for fermentation, it has drawbacks such as being expensive, producing a bad odor during fermentation, and requiring a long fermentation time. Methods for producing phosphorus antibiotics are not always satisfactory.
問題点を解決するための手段
本発明者らは、セファロスポリン系抗生物質製造におい
て、発酵原料にメチオニンを用いることなく、収率の高
いセファロスポリン系抗生物質の製造法を確立すべく種
々研究を重ねた結果、本発明を完成した。Means for Solving the Problems The present inventors have conducted various efforts in the production of cephalosporin antibiotics in order to establish a method for producing cephalosporin antibiotics with high yield without using methionine as a fermentation raw material. As a result of repeated research, the present invention was completed.
すなわち本発明は、セファロスポリウム属に属し、セフ
ァロスポリン系抗生物質生産能を有する微生物を培地に
培養してセファロスポリン系抗生物質を製造する方法に
おいて、培地にチオ硫酸塩に加え、アラニン、セリン、
ピルビン酸、&−ケトグルタル酸、2−ケト酪酸、クエ
ン酸およびオキザロ酢酸から選ばれる1種以上の化合物
を添加することを特徴とする製造法を提供するものであ
る。That is, the present invention provides a method for producing cephalosporin antibiotics by culturing microorganisms belonging to the genus Cephalosporium and having the ability to produce cephalosporin antibiotics in a medium, in which thiosulfate is added to the medium, and alanine is added to the medium. , Serin,
The present invention provides a production method characterized by adding one or more compounds selected from pyruvic acid, &-ketoglutaric acid, 2-ketobutyric acid, citric acid, and oxaloacetic acid.
セファロスポリン系抗生物質としては、セファロスポリ
ン系、セファマイシン系のいずれの抗生物質でもよいが
、例えば、セファロスポリンC(以下の式で、RがOC
OCH3の化合物。以下rCPC」と略称する)、デア
セチルセファロスポリンC(以下の式で、RがOHの化
合物。以下rDcPcJと略称する)が挙げられる。The cephalosporin antibiotic may be either a cephalosporin or cephamycin antibiotic, but for example, cephalosporin C (in the following formula, R is OC
Compound of OCH3. (hereinafter abbreviated as "rCPC"), and deacetylcephalosporin C (a compound in the following formula in which R is OH; hereinafter abbreviated as rDcPcJ).
チオ硫酸塩の具体例としては、チオ硫酸の無機塩か好ま
しく、たとえば、チオ硫酸アンモニウム。As a specific example of thiosulfate, inorganic salts of thiosulfate are preferred, such as ammonium thiosulfate.
チオ硫酸ナトリウム、チオ硫酸カリウムなどがあげられ
る。Examples include sodium thiosulfate and potassium thiosulfate.
上記アラニン、セリン、ピルビン酸、α−ケトグルタル
酸、2−ケト酪酸、クエン酸およびオキザロ酢酸に関し
、これらの化合物が光学活性体として存在しうる場合は
、光学活性体でもよく、またラセミ体でも有利に使用し
うる。またこれらの化合物が塩を形成しうる場合は、塩
として用いることらできる。Regarding the above alanine, serine, pyruvate, α-ketoglutaric acid, 2-ketobutyric acid, citric acid, and oxaloacetic acid, if these compounds can exist as optically active forms, they may be optically active forms, and racemic forms are also advantageous. It can be used for Furthermore, when these compounds can form salts, they can be used as salts.
これらの化合物は、単独で使用してもよく、また一種以
上、例えば二種、三種を併用してもよい。These compounds may be used alone, or one or more kinds, for example, two or three kinds, may be used in combination.
さらに、所望により上記化合物に加え、グルタミン酸ま
たはグリシンをさらに添加することもできる。Furthermore, if desired, glutamic acid or glycine can be further added in addition to the above compounds.
本発明の方法で用いられる微生物は、セファロスポリウ
ム属に属し、セファロスポリン系抗生物質の一種または
それ以上を生産する能力を有するものであればすべて本
発明方法に使用しうる。セファロスポリウム属に属する
微生物とは、その微生物が、たとえばマイコロシア(M
ycologia)第55巻563頁(1963年)、
第58巻351頁(1966年)、ラーベンホルスト著
、クリプトガメンフロラ(Raben −horst、
Kryptogamenflora der Mark
brandenburg■。Any microorganism that belongs to the genus Cephalosporium and has the ability to produce one or more cephalosporin antibiotics can be used in the method of the present invention. Microorganisms belonging to the genus Cephalosporium are those that belong to the genus Cephalosporium.
ycologia) Vol. 55, p. 563 (1963),
Volume 58, page 351 (1966), Rabenhorst, Cryptogamenflora (Raben-horst)
Kryptogamenflora der Mark
brandenburg ■.
1907)などによって分類されるセファロスポリウム
属に属するものをいう。1907), etc., which belong to the genus Cephalosporium.
本発明の方法で用いられる微生物の具体例としては、た
とえば、CPCの生産において、セファロスポリウム・
ポリアレリウム(Cephalospori−ua+
polyaleriun+)199 (F E RM
−PNo、 l I 59 ;IFo 9394.A
TCC−20359)、セファロスポリウム・ポリアレ
リウムY505(FERM−PNo、1160;IFO
9535;ATCC−20360)、セファロスポリウ
ム・アクレモニウム(Cephalosporium
acremonium) 2 M −16(FERM−
PNo、2283;IFO9999;ATCC−204
25)、セファロスポリウム・アクレモニウムLA−1
01(FERM−PNo、2284;IFo 300
1;ATCC−20426)、セファロスボリウム・ア
クレモニウムに−121(FERM PNo、228
5;IFO9998;ATCC−20427)、セファ
ロスポリウム・アクレモニウムN −75(PERM−
PNo、2286 ;I Fo 9997、ATCC
−20428)などがそれぞれあげられる。Specific examples of microorganisms used in the method of the present invention include, for example, Cephalosporium spp.
Polyallerium (Cephalospori-ua+
polyaleriun+)199 (F E RM
-PNo, lI59; IFo9394. A
TCC-20359), Cephalosporium polyallerium Y505 (FERM-PNo, 1160; IFO
9535; ATCC-20360), Cephalosporium acremonium
acremonium) 2 M-16 (FERM-
PNo. 2283; IFO9999; ATCC-204
25), Cephalosporium acremonium LA-1
01 (FERM-PNo, 2284; IFo 300
1; ATCC-20426), Cephalosborium acremonium -121 (FERM PNo, 228
5; IFO9998; ATCC-20427), Cephalosporium acremonium N-75 (PERM-
PNo. 2286; I Fo 9997, ATCC
-20428), etc.
またDCPCの生産においては、セファロスポリウム・
アクレモニウムC−28(C−28(FER,I430
;IFO9537;ATCC−20370、なお本株は
セファロスポリウムsp、c−28とも称される)など
があげられる。In addition, in the production of DCPC, cephalosporium
Acremonium C-28 (C-28 (FER, I430)
; IFO9537; ATCC-20370, and this strain is also called Cephalosporium sp, c-28).
上記において、FERM−Pで表わされる番号は、工業
技術院微生物工業技術研究所の微生物受託番号を、TP
Oで表わされる番号は財団法人発酵研究所の微生物受託
番号を、ATCCで表わされる番号はジ・アメリカン・
タイプ・カルチャー・コレクション(The Amer
ican Type Cu1tureCol 1ect
ion)(米国)(以下、rATccJと略称する)の
微生物寄託番号を、それぞれ表わす。In the above, the number represented by FERM-P is the microbial accession number of the National Institute of Microbial Technology, Agency of Industrial Science and Technology.
The number represented by O is the microorganism accession number of the Fermentation Research Institute, and the number represented by ATCC is the number of the American Fermentation Research Institute.
Type Culture Collection (The Amer)
ican Type CultureCol 1ect
ion) (USA) (hereinafter abbreviated as rATccJ), respectively.
上記の菌において、ATCCの寄託番号の付されている
ものは、いずれらATCCの1978年13版カタログ
・オブ・ストレインズに収載されており、ATCCから
人手可能な菌である。また、セファロスポリウム・ポリ
アレリウムIP0 9394株は、財団法人発酵研究所
の1978年版リスト・オブ・カルチャーズ(Inst
itute forFermentation 0s
aka Li5t of Cu1tures
1978Sixth Edition)に収載されてお
り、財団法人発酵研究所から入手可能な菌である。Among the above bacteria, those with ATCC deposit numbers are listed in ATCC's 1978 Catalog of Strains, 13th edition, and are bacteria that can be handled manually by ATCC. In addition, Cephalosporium polyallerium IP0 9394 strain is included in the 1978 List of Cultures of the Fermentation Research Institute (Inst.
Itute for Fermentation 0s
aka Li5t of Cultures
1978 Sixth Edition) and is available from the Fermentation Research Institute.
本発明で用いられる菌の培養に際しては、閑が同化しう
る炭素源、資化しうる窒素源その他を含有する培地が用
いられる。炭素源としては同化しうるちのであれば何で
もよくたとえば、グルコース、シュークロース、澱粉、
可溶性澱粉、グリセリン。When culturing the bacteria used in the present invention, a medium containing an assimilable carbon source, an assimilable nitrogen source, and the like is used. As a carbon source, any assimilable material can be used, such as glucose, sucrose, starch,
Soluble starch, glycerin.
n−パラフィン、酢酸、フマール酸、安息香酸などの有
機酸類、エタノール、ブタノールなどのアルコール類、
油脂類(ラード油)などが、単独または混合して用いら
れる。また窒素源としては例えばペプトン、大豆粉、肉
エキス、綿実粉、乾燥酵母、酵母エキス、コーン・スチ
ープ・リカー、プロフロ(トレイダース・プロティン・
ディビジョン社製)、コーン・グルテン・ミール、尿素
、アンモニウム塩類(例、塩化アンモニウム)、硝酸塩
類(例、硝酸カリウム)、その他有機または無機の窒素
含有物(例、NZアミン(A)、硫安)が単独でまたは
混合して用いられる。その他培地成分の無機塩としては
、各種リン酸塩(例、リン酸カリウム)、硫酸塩(例、
硫酸ナトリウム)、塩酸塩(例、塩化マグネシウム)な
どが用いられる。鉄、マグネシウム、カルシウム。Organic acids such as n-paraffin, acetic acid, fumaric acid, and benzoic acid; alcohols such as ethanol and butanol;
Fats and oils (lard oil) are used alone or in combination. Examples of nitrogen sources include peptone, soybean flour, meat extract, cottonseed flour, dried yeast, yeast extract, corn steep liquor, and proflo (traders protein).
Division), corn gluten meal, urea, ammonium salts (e.g. ammonium chloride), nitrates (e.g. potassium nitrate), and other organic or inorganic nitrogen-containing substances (e.g. NZ amine (A), ammonium sulfate). Used alone or in combination. Other inorganic salts of medium components include various phosphates (e.g., potassium phosphate), sulfates (e.g.,
(sodium sulfate), hydrochloride (eg, magnesium chloride), etc. iron, magnesium, calcium.
マンガン、コバルトなどの各イオンの添加は菌の生育お
よびセファロスポリン系抗生物質の生産、安定性などに
関係が深い。The addition of ions such as manganese and cobalt is closely related to the growth of bacteria and the production and stability of cephalosporin antibiotics.
これら使用する培地原料は使用する菌株、培養に利用す
る条件などに応じて適宜に組み合わせもしくは選択され
うる。These medium materials to be used can be appropriately combined or selected depending on the bacterial strain used, the conditions used for culture, etc.
チオ硫酸塩の培地への添加量は、菌株の生育を阻害しな
ければいくらでもよく、また生育用の基本培地およびフ
ィード培地のいずれにも添加することができ、例えば約
0.3〜5%(W/V) 、好ましくは約0.5〜2%
(ml/V)添加する。とりわけ、チオ硫酸塩を基本培
地に1,5の割合に対し、フィード培地に約1.0の割
合で加えるのが好ましい。Any amount of thiosulfate can be added to the medium as long as it does not inhibit the growth of the bacterial strain, and it can be added to both the basic growth medium and the feed medium, for example, about 0.3 to 5% ( W/V), preferably about 0.5-2%
(ml/V). In particular, it is preferred to add thiosulfate to the base medium in a ratio of 1.5 to the feed medium in a ratio of about 1.0.
上記アラニン、セリン、ピルビン酸、α−ケトグルタル
酸、2−ケト酪酸、クエン酸およびオキザロ酢酸の添加
量については、例えば培地に約0.2〜3.0%U/V
)、好ましく 4!0.3〜1.5%(W/V)を添加
する。二種以上添加する場合も、それぞれの化合物の全
量を約0.2〜3.0%(W/V)とするのが好ましい
。The amounts of alanine, serine, pyruvate, α-ketoglutaric acid, 2-ketobutyric acid, citric acid, and oxaloacetic acid added to the medium are, for example, about 0.2 to 3.0% U/V.
), preferably 4!0.3 to 1.5% (W/V) is added. Even when two or more kinds of compounds are added, the total amount of each compound is preferably about 0.2 to 3.0% (W/V).
これらの化合物は、フィード培地に加えることが好まし
く、さらにグルタミン酸、グリシン等を加える場合も、
上記の量で同様に加えることができる。These compounds are preferably added to the feed medium, and when further adding glutamic acid, glycine, etc.
It can be added in the same manner as above.
実際の培養にあたっての培養温度、培養期間、培地のp
H1通気攪拌などの培養条件は使用する菌株、培地組成
などによって一定しないが、目的とするセファロスポリ
ン系抗生物質の蓄積量が最大となるよう選択調節されれ
ばよい。多くの場合、培養温度は20〜37℃、培養期
間は96〜336時間、培地のpH5,0〜9.0であ
り、好気的に培養を行なうことが好ましい。Culture temperature, culture period, and medium p during actual culture
Culture conditions such as H1 aeration and stirring vary depending on the strain used, medium composition, etc., but may be selectively adjusted so as to maximize the accumulation of the desired cephalosporin antibiotic. In most cases, the culture temperature is 20 to 37°C, the culture period is 96 to 336 hours, and the pH of the medium is 5.0 to 9.0, and it is preferable to perform the culture aerobically.
作用および実施例
以下に本発明を実施例により具体的に説明するが、これ
により本発明の内容が制限されるものではない。Effects and Examples The present invention will be specifically explained below using Examples, but the content of the present invention is not limited thereby.
なお、実施例で開示する菌株セファロスポリウム・アク
レモニウムに−121および同C−18については、F
RIにそれぞれFERM−PNo。In addition, for the bacterial strains Cephalosporium acremonium-121 and Cephalosporium acremonium C-18 disclosed in the Examples, F.
FERM-P No. for each RI.
2285およびFERM−PNo、1430として寄託
されている。2285 and FERM-PNo. 1430.
実施例! 本発明の添加物を培地に添加した場合のcpc。Example! cpc when the additive of the present invention is added to the medium.
DCPCの生成量を示す。The amount of produced DCPC is shown.
なお、微生物はCPC生産菌についてはセファロスポリ
ウム・アクレモニウムに−121を、DCPC生産菌に
ついてはセファロスポリウム・アクレモニウムC−28
を使い、基本培地およびフィード培地は下記の表3に示
したものを用い、チオ硫酸塩としてチオ硫酸アンモニウ
ムと各化合物を表1に示す量を加えた。培養は、28℃
で60時間、その後25℃で240時間振盪培養で行っ
た。The microorganisms used were Cephalosporium acremonium -121 for CPC-producing bacteria, and Cephalosporium acremonium C-28 for DCPC-producing bacteria.
The basal medium and feed medium shown in Table 3 below were used, and ammonium thiosulfate as thiosulfate and each compound were added in the amounts shown in Table 1. Culture at 28℃
for 60 hours, followed by shaking culture at 25° C. for 240 hours.
培地中におけるCPCおよびDCPCの生成量を表1に
示す。Table 1 shows the amounts of CPC and DCPC produced in the medium.
表1
(チオ硫酸塩としてナトリウム塩、カリウム塩を用いて
も同様の結果を得た)
このように、本発明の添加物を培地に添加し培養するこ
とにより、メチオニン添加培養と同等のCPC,DCP
C主PCを得ることが出来る。Table 1 (Similar results were obtained using sodium salt and potassium salt as thiosulfate) As described above, by adding the additive of the present invention to the culture medium and culturing, CPC, which is equivalent to methionine-added culture, DCP
You can get a C main PC.
実施例2
セファロスポリウム・アクレモニウムに−121をブイ
ヨンスラント上にて28°C,120時間生育させたの
ち表2に示す栄養素を含む液体培地(pH7,6)30
0mlに1白金耳接種し、28℃で168時間t!iL
盪培養した。次に4Qジヤーフアメンタ中の表3に示す
基本培地1.612にこの培養液を接種した。Example 2 After growing Cephalosporium acremonium -121 on a bouillon slant at 28°C for 120 hours, a liquid medium containing the nutrients shown in Table 2 (pH 7,6) 30
One platinum loopful was inoculated into 0ml and incubated at 28°C for 168 hours! iL
It was cultured. Next, this culture solution was inoculated into the basal medium 1.612 shown in Table 3 in 4Q Jahuamenta.
さらに表に示すフィード培地2Qを一定速度で連続的に
添加し、24〜32℃、1)86.0〜7.6゜1θ〜
!3日間通気攪拌したのち、培養ろ液についてCPC含
量を測定した。その結果を表4に示した。また基本培地
、フィード培地への添加物は表4に示した。Furthermore, feed medium 2Q shown in the table was added continuously at a constant rate, and the temperature was 24-32°C.
! After aeration and stirring for 3 days, the CPC content of the culture filtrate was measured. The results are shown in Table 4. Additionally, additives to the basic medium and feed medium are shown in Table 4.
表2
表3
表4
実施例3
セファロスポリウム・アクレモニウムC−28をブイヨ
ンスラント上にて28°C,120時間生育させたのち
、表2に示す栄養素を含む液体培地(pH7,6)30
0IIllに1白金耳接種し、28℃で168時間振盪
培養した。Table 2 Table 3 Table 4 Example 3 After growing Cephalosporium acremonium C-28 on a bouillon slant at 28°C for 120 hours, it was grown in a liquid medium (pH 7,6) containing the nutrients shown in Table 2.
0IIll was inoculated with one platinum loop, and cultured with shaking at 28°C for 168 hours.
次に412ジヤーフアメンタ中の表3に示す基本培地1
.6(にこの培養液を接種した。さらに表3に示すフィ
ード培地2eを一定速度で連続的に添加し、24〜32
°(:、pH6,0〜7.6.10〜13日間通気攪拌
したのち、培養ろ液についてDCPC含量を測定した。Next, the basic medium 1 shown in Table 3 in 412 Jarhuamenta
.. 6 (inoculated with this culture solution.Furthermore, feed medium 2e shown in Table 3 was added continuously at a constant rate,
°(:, pH 6.0 to 7.6. After aeration and stirring for 10 to 13 days, the DCPC content of the culture filtrate was measured.
その結果を表5に示した。また基本培地、フィード培地
への添加物は表5に示した。The results are shown in Table 5. Additionally, additives to the basic medium and feed medium are shown in Table 5.
発明の効果
本発明の製造法により、培地にメチオニンを添加するこ
となくセファロスポリン系抗生物質を高収率で製造する
ことができ、また培養時間も短縮することができる。Effects of the Invention According to the production method of the present invention, cephalosporin antibiotics can be produced in high yield without adding methionine to the culture medium, and the culture time can also be shortened.
Claims (1)
物質生産能を有する微生物を培地に培養してセファロス
ポリン系抗生物質を製造する方法において、培地にチオ
硫酸塩に加え、アラニン、セリン、ピルビン酸、α−ケ
トグルタル酸、2−ケト酪酸、クエン酸およびオキザロ
酢酸から選ばれる1種以上の化合物を添加することを特
徴とする製造法。In a method for producing cephalosporin antibiotics by culturing microorganisms belonging to the genus Cephalosporium and having the ability to produce cephalosporin antibiotics in a medium, in addition to thiosulfate, alanine, serine, and pyruvate are added to the medium. , α-ketoglutaric acid, 2-ketobutyric acid, citric acid, and oxaloacetic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8032786A JPH0612997B2 (en) | 1986-04-08 | 1986-04-08 | Manufacturing method of cephalosporin antibiotics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8032786A JPH0612997B2 (en) | 1986-04-08 | 1986-04-08 | Manufacturing method of cephalosporin antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62236500A true JPS62236500A (en) | 1987-10-16 |
JPH0612997B2 JPH0612997B2 (en) | 1994-02-23 |
Family
ID=13715161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8032786A Expired - Lifetime JPH0612997B2 (en) | 1986-04-08 | 1986-04-08 | Manufacturing method of cephalosporin antibiotics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0612997B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102808011A (en) * | 2012-08-28 | 2012-12-05 | 伊犁川宁生物技术有限公司 | Fermentation method for cephalosporin C |
-
1986
- 1986-04-08 JP JP8032786A patent/JPH0612997B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102808011A (en) * | 2012-08-28 | 2012-12-05 | 伊犁川宁生物技术有限公司 | Fermentation method for cephalosporin C |
Also Published As
Publication number | Publication date |
---|---|
JPH0612997B2 (en) | 1994-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2595499A (en) | Process for production of vitamin b12 | |
US3945888A (en) | Method for the production of cephalosporins | |
US4307192A (en) | Cell-free synthesis of deacetoxycephalosporin C | |
Erickson et al. | Penicillin acylase activity of Penicillium chrysogenum | |
US3816260A (en) | Bacterial cellwall lytic enzyme and process for producing the same | |
DE2313546A1 (en) | MICROBIAL PROTEASE AND METHOD FOR PRODUCING IT | |
US3770590A (en) | Fermentation process | |
GB2058776A (en) | Esters and their use in the synthesis of -lactam antibacterial compounds | |
KR890005139A (en) | Teicoplanin-like derivatives | |
JPS62236500A (en) | Production of cephalosporin-type antibiotic substance | |
US3769169A (en) | Fermentation process | |
GB2086913A (en) | Improvements in enzymatic deesterification | |
D'Amato et al. | A chemically defined medium for cephalosporin C production by Paecilomyces persicinus | |
US2831797A (en) | Cephalosporin n production | |
US3562110A (en) | Production of amino acids | |
US4723004A (en) | Cephem compounds | |
JPS6225358B2 (en) | ||
US3902968A (en) | Fermentation process | |
KR0134131B1 (en) | Cephalosporium which produces cephalosporin and process for cephalosporin | |
US3977942A (en) | Fermentation of cephamycin C | |
US3886044A (en) | Process of making cephamycin C by fermentation | |
JPS6251117B2 (en) | ||
US3116216A (en) | Production of cephalosporin c by fermentation | |
KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
US4520101A (en) | Production of cephalosporin C |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |